1st June, 2016

With the news of his appointment, Jeremy Haigh commented,

'I am delighted to be joining Proteome Sciences at a time of tremendous opportunity. The challenge of developing more precise therapeutics coupled with growing patient expectations is creating a highly receptive environment for our enabling technologies and I look forward to working with the board and the entire team to realise this potential.'

Christopher Pearce added,

'As Chairman, I look forward to working closely with Jeremy and the executive team to help them exploit the considerable commercial opportunities arising in Precision Medicine from the outstanding proteomics platform Proteome Sciences has established to deliver truly personalized medicine.' Read More

Proteome Sciences plc published this content on 01 June 2016 and is solely responsible for the information contained herein.
Distributed by Public, unedited and unaltered, on 01 June 2016 06:01:04 UTC.

Original documenthttp://www.proteomics.com/news-and-events/news/post/ceo-appointment-2

Public permalinkhttp://www.publicnow.com/view/57F42FA09AE249F0FB346B17DF4C1AA73BAF2C92